3De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
4Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
5Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
6De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
7De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
8Van Der Gaast a,Kok TC,Ves R,et al.A phase Ⅰ dose finding study of a biweekly schedule of a fixed doee of cisplatin with increasing dose of paclitaxel in patients with advanced esophageal cancer.Semin oncol,1997,24Suppl 19:82-85.
9Nogles E,Wolf SG,Khan IA.Structure of tubulin at 6.5A and location of the taxal-binding site.Nature,1995,375:235-238.
10Muiline DW,Burger CJ,Elgert CD.Paclitaxel enhances macrophage IL-12 production in tumor beari-ng hosts through nitric oxide.J Immunol,1999,162:6811-6818.
